Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Shares Outstanding (Weighted Average): 2012-2024

Historic Shares Outstanding (Weighted Average) for Veracyte (VCYT) over the last 13 years, with Dec 2024 value amounting to $77.5 million.

  • Veracyte's Shares Outstanding (Weighted Average) rose 2.42% to $78.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.7 million, marking a year-over-year increase of 2.42%. This contributed to the annual value of $77.5 million for FY2024, which is 6.11% up from last year.
  • As of FY2024, Veracyte's Shares Outstanding (Weighted Average) stood at $77.5 million, which was up 6.11% from $73.0 million recorded in FY2023.
  • In the past 5 years, Veracyte's Shares Outstanding (Weighted Average) registered a high of $77.5 million during FY2024, and its lowest value of $57.9 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $74.1 million, with a median of $73.0 million in 2023.
  • Data for Veracyte's Shares Outstanding (Weighted Average) shows a peak YoY grew of 22.71% (in 2021) over the last 5 years.
  • Veracyte's Shares Outstanding (Weighted Average) (Yearly) stood at $57.9 million in 2020, then climbed by 22.71% to $71.0 million in 2021, then grew by 1.00% to $71.8 million in 2022, then rose by 1.79% to $73.0 million in 2023, then rose by 6.11% to $77.5 million in 2024.